Evidence map›Paper›PMID 25803861›Full record

ArticlePloS one2015

Alcohol use disorder with and without stimulant use: brain morphometry and its associations with cigarette smoking, cognition, and inhibitory control.

David L Pennington, Timothy C Durazzo, Thomas P Schmidt, Christoph Abé, Anderson Mon, Dieter J Meyerhoff

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 3 countries.

David L PenningtonAddiction Research Program, Veterans Administration Medical Center, San Francisco, California, United States of America; Northern California Institute for Research and Education, San Francisco, California, United States of America.
Timothy C DurazzoDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, California, United States of America; Center for Imaging of Neurodegenerative Diseases, Veterans Administration Medical Center, San Francisco, California, United States of America.
Thomas P SchmidtDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, California, United States of America.
Christoph AbéDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Anderson MonSchool of Applied Sciences and Statistics, Koforidua Polytechnic, Ghana.
Dieter J MeyerhoffDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, California, United States of America; Center for Imaging of Neurodegenerative Diseases, Veterans Administration Medical Center, San Francisco, California, United States of America.
University of California, San Francisco · USKarolinska Institutet · SEKoforidua Technical University · GHNorthern California Institute for Research and Education · USSan Francisco VA Medical Center · US

Funding

The Biological Basis of Alcohol Induced Brain DamageR01AA010788 · NIAAA · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI MEYERHOFF, DIETER J · 1996 to 2016
$8.9M
The Neurobiological and Neurocognitive Consequences of Chronic Cigarette SmokingK01DA024136 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DURAZZO, TIMOTHY CRAIG · 2008 to 2012
$785k
Polysubstance Use and Chronic Smoking: Neuroimaging and CognitionR21DA025202 · NIDA · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI MEYERHOFF, DIETER J · 2009 to 2010
$426k
NIAAA NIH HHS AA10788NIAAA NIH HHS R01 AA010788NIDA NIH HHS DA025202NIDA NIH HHS DA24136NIDA NIH HHS K01 DA024136NIDA NIH HHS R21 DA025202
6 · The paper itself

Abstract

objectiveLittle is known about the effects of polysubstance use and cigarette smoking on brain morphometry. This study examined neocortical brain morphometric differences between abstinent polysubstance dependent and alcohol-only dependent treatment seekers (ALC) as well as light drinking controls (CON), the associations of cigarette smoking in these polysubstance users (PSU), and morphometric relationships to cognition and inhibitory control.

methodsAll participants completed extensive neuropsychological assessments and 4 Tesla brain magnetic resonance imaging. PSU and ALC were abstinent for one month at the time of study. Parcellated morphological data (volume, surface area, thickness) were obtained with FreeSurfer methodology for the following bilateral components: dorso-prefrontal cortex (DPFC), anterior cingulate cortex (ACC), orbitofrontal cortex (OFC), and insula. Regional group differences were examined and structural data correlated with domains of cognition and inhibitory control.

resultsPSU had significantly smaller left OFC volume and surface area and trends to smaller right DPFC volume and surface area compared to CON; PSU did not differ significantly from ALC on these measures. PSU, however, had significantly thinner right ACC than ALC. Smoking PSU had significantly larger right OFC surface area than non-smoking PSU. No significant relationships between morphometry and quantity/frequency of substance use, alcohol use, or age of onset of heavy drinking were observed. PSU exhibited distinct relationships between brain structure and processing speed, cognitive efficiency, working memory and inhibitory control that were not observed in ALC or CON.

conclusionPolysubstance users have unique morphometric abnormalities and structure-function relationships when compared to individuals dependent only on alcohol and light drinking controls. Chronic cigarette smoking is associated with structural brain irregularities in polysubstance users. Further elucidation of these distinctive characteristics could help inform the development of targeted and thus potentially more effective treatments in this large but understudied population.

Indexed as

Inhibition, PsychologicalAdultAlcoholismAmphetaminesAnalgesics, OpioidCannabisCentral Nervous System StimulantsCocaineCognitionHumansMagnetic Resonance ImagingMiddle AgedNeocortexNeuropsychological TestsSmokingAmphetaminesAnalgesics, OpioidCentral Nervous System StimulantsCocaine

Identifiers

PMID25803861
PMCPMC4372577
OpenAlexW1974608613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.